Tiagabine ethyl ester hydrochloride and preparation method thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 凯默斯医药科技上海有限公司
- Publication Date
- 2014-02-05
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to tiagabine ethyl ester hydrochloride and a preparation method thereof. Background technique
[0002] Tiagabine hydrochloride (Tiagabine hydrochloride, 1) is the first marketed neuron and glial γ-aminobutyric acid (GABA) reuptake selective and reversible inhibitor, which can inhibit mediator transmission in the central nervous system, It increases the concentration of GABA in the synapse and reduces the sensitivity of nerve excitation. It is an antiepileptic drug with a very clear mechanism of action. The chemical name of tiagabine hydrochloride is (R)-(-)-N-[4,4-bis-(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylic acid Hydrochloride, the structural formula is as follows:
[0003]
[0004] The synthetic route of the now reported tiagabine hydrochloride mainly takes 2-bromo-3-methylthiophene as starting material, synthesizes N-alkylating reagent by different methods, and then reacts with chiral ethyl piperidinecarboxyla...